Literature DB >> 19041112

Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion.

Lulin Hu1, Kendra Plafker, Valeriya Vorozhko, Rosemary E Zuna, Marie H Hanigan, Gary J Gorbsky, Scott M Plafker, Peter C Angeletti, Brian P Ceresa.   

Abstract

Human papillomaviruses (HPV) 16 is a DNA virus encoding three oncogenes--E5, E6, and E7. The E6 and E7 proteins have well-established roles as inhibitors of tumor suppression, but the contribution of E5 to malignant transformation is controversial. Using spontaneously immortalized human keratinocytes (HaCaT cells), we demonstrate that expression of HPV16 E5 is necessary and sufficient for the formation of bi-nucleated cells, a common characteristic of precancerous cervical lesions. Expression of E5 from non-carcinogenic HPV6b does not produce bi-nucleate cells. Video microscopy and biochemical analyses reveal that bi-nucleates arise through cell-cell fusion. Although most E5-induced bi-nucleates fail to propagate, co-expression of HPV16 E6/E7 enhances the proliferation of these cells. Expression of HPV16 E6/E7 also increases bi-nucleated cell colony formation. These findings identify a new role for HPV16 E5 and support a model in which complementary roles of the HPV16 oncogenes lead to the induction of carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041112      PMCID: PMC2658674          DOI: 10.1016/j.virol.2008.10.011

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  47 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6.

Authors:  Annemieke W Plug-DeMaggio; Terri Sundsvold; Michelle A Wurscher; Jennifer I Koop; Aloysius J Klingelhutz; James K McDougall
Journal:  Oncogene       Date:  2004-04-29       Impact factor: 9.867

3.  Carcinogenicity of human papillomaviruses.

Authors:  Vincent Cogliano; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi
Journal:  Lancet Oncol       Date:  2005-04       Impact factor: 41.316

4.  HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes.

Authors:  Benyue Zhang; Anjaiah Srirangam; David A Potter; Ann Roman
Journal:  Oncogene       Date:  2005-04-07       Impact factor: 9.867

5.  The reversibility of mitotic exit in vertebrate cells.

Authors:  Tamara A Potapova; John R Daum; Bradley D Pittman; Joanna R Hudson; Tara N Jones; David L Satinover; P Todd Stukenberg; Gary J Gorbsky
Journal:  Nature       Date:  2006-04-13       Impact factor: 49.962

6.  Codon optimization of the HPV-16 E5 gene enhances protein expression.

Authors:  Gary L Disbrow; Iruvanti Sunitha; Carl C Baker; John Hanover; Richard Schlegel
Journal:  Virology       Date:  2003-06-20       Impact factor: 3.616

7.  Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

Authors:  Nubia Muñoz; F Xavier Bosch; Xavier Castellsagué; Mireia Díaz; Silvia de Sanjose; Doudja Hammouda; Keerti V Shah; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

8.  The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma.

Authors:  Benyue Zhang; Ping Li; Exing Wang; Zacharie Brahmi; Kenneth W Dunn; Janice S Blum; Ann Roman
Journal:  Virology       Date:  2003-05-25       Impact factor: 3.616

9.  The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells.

Authors:  G F Valle; L Banks
Journal:  J Gen Virol       Date:  1995-05       Impact factor: 3.891

10.  The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors.

Authors:  M Conrad; D Goldstein; T Andresson; R Schlegel
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

View more
  21 in total

1.  The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.

Authors:  Frank A Suprynowicz; Ewa Krawczyk; Jess D Hebert; Sawali R Sudarshan; Vera Simic; Christopher M Kamonjoh; Richard Schlegel
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

2.  A non-invasive technique for quantifying and isolating fused cells.

Authors:  Lulin Hu; Kendra Plafker; James Henthorn; Brian P Ceresa
Journal:  Cytotechnology       Date:  2009-02-28       Impact factor: 2.058

3.  Membrane orientation of the human papillomavirus type 16 E5 oncoprotein.

Authors:  Ewa Krawczyk; Frank A Suprynowicz; Sawali R Sudarshan; Richard Schlegel
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

4.  Binucleated HeLa cells are formed by cytokinesis failure in starvation and keep the potential of proliferation.

Authors:  Kazunori Nishimura; Sumiko Watanabe; Ryo Hayashida; Setsuo Sugishima; Tsuyoshi Iwasaka; Tsunehisa Kaku
Journal:  Cytotechnology       Date:  2015-04-18       Impact factor: 2.058

5.  HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy.

Authors:  Francesca Paolini; Gianfranca Curzio; Marcelo Nazario Cordeiro; Silvia Massa; Luciano Mariani; Fulvia Pimpinelli; Antonio Carlos de Freitas; Rosella Franconi; Aldo Venuti
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

Review 6.  Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.

Authors:  Niladri Ganguly
Journal:  Cell Oncol (Dordr)       Date:  2012-01-20       Impact factor: 6.730

7.  Preparation and optimisation of anionic liposomes for delivery of small peptides and cDNA to human corneal epithelial cells.

Authors:  Luís F Neves; Jinghua Duan; Adrienne Voelker; Anil Khanal; Lacey McNally; Jill Steinbach-Rankins; Brian P Ceresa
Journal:  J Microencapsul       Date:  2016-08-10       Impact factor: 3.142

Review 8.  Polyploidy in liver development, homeostasis and disease.

Authors:  Romain Donne; Maëva Saroul-Aïnama; Pierre Cordier; Séverine Celton-Morizur; Chantal Desdouets
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-02       Impact factor: 46.802

9.  High-risk HPV E5-induced cell fusion: a critical initiating event in the early stage of HPV-associated cervical cancer.

Authors:  Peng Gao; Jie Zheng
Journal:  Virol J       Date:  2010-09-16       Impact factor: 4.099

10.  Characterization of the plasma membrane localization and orientation of HPV16 E5 for cell-cell fusion.

Authors:  Lulin Hu; Brian P Ceresa
Journal:  Virology       Date:  2009-08-26       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.